• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka

Evidence-Based Management of the Acute Coronary Syndrome

9781560534587
379,00 zł
341,00 zł Zniżka 38,00 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 341,00 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Acute coronary syndrome (ACS) is at present the most common clinical entity requiring admission of a patient to an inpatient cardiology service. In the past, evaluation and treatment options for patients with this syndrome were either empirical or based on observational reports of clinical outcomes. Recent clinical trials have resulted in a deeper, evidence-based understanding of the pathophysiology, presentation, risk assessment, and management of the acute coronary syndrome and its subsets (e.g., unstable angina and myocardial infarction). This book organizes the data gleaned from these trials to present the best use of individual forms of evaluation and treatment to provide optimal patient outcome. It is a clear, concise source for everything the cardiologist, cv surgeon, emergency physician or others on the frontlines of caring for patients with chest pain need to know and the only book on this topic that is evidence-based.
Szczegóły produktu
Hanley & Belfus
32430
9781560534587
9781560534587

Opis

Rok wydania
2001
Numer wydania
1
Oprawa
twarda
Liczba stron
477
Waga (g)
848
  • Pathophysiology of the Acute Coronary Syndrome - Louis S. McKeever, MD
    Clinical Presentation and Diagnosis (including Triggering) - Keith McLean, MD
    Risk Factor Stratification and Acute Coronary Syndromes - David L. Smull, DO
    Medical Treatment of the Acute Coronary Syndrome
    Antiplatelet Agents in Acute Coronary Syndromes - James M. Wilson, MD
    Heparin in Acute Coronary Syndromes - Diane E. Wallis, MD
    Low-molecular-weight Heparins in Acute Coronary Syndromes - Eric D. Grassman, MD, PhD
    Antithrombin Agents:: The New Class of Antithrombotic Drugs -Jawed Fareed, PhD
    Thrombolytic Therapy in Acute Coronary Syndrome - Omer Iqubal, MD
    Oral Anticoagulation in Acute Coronary Syndromes - G. Steinar Gudmundsson, MD
    Beta Blockers in Acute Coronary Syndromes - Sudhakar B. Chennareddy, MD
    Calcium Antagonists for the Acute Coronary Syndromes - Fundador L. Adajar, MD
    Nitrates in the Acute Coronary Syndromes - Kevin J. Cochran, MD
    Antiarrhythmic Therapy in the Management of Acute Coronary Syndromes - Martin C. Burke, MD
    The Use of Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Acute Coronary Syndromes - Venkatesh K. Raman, MD
    Other Pharmacologic Agents for Acute Coronary Syndromes - Henry Demots, MD
    Interventional Management of the Acute Coronary Syndrome
    Role of Coronary Angiography in the Evaluation of Patients with Acute Coronary Syndromes - Gregory J. Dehmer, MD
    The Essential Role of Percutaneous Coronary Interventions in the Management of Acute Coronary Syndromes - Gary E. Lane, MD
    Surgical Management of the Acute Coronary Syndrome
    Surgical Intervention for Acute Coronary Syndromes - J. Michael Tuchek, MD
    Anesthetic Considerations for Patients with Acute Myocardial Infarction Undergoing Cardiac Surgery - William C. Oliver, Jr., MD
    Myocardial Protection for Patients with Acute Evolving Myocardial Infarction Undergoing Cardiac Surgery - Mark Chaney, MD
    Mechanical Support for Patients with Acute Coronary Syndromes - Richard J. Kaplon, MD
    Left Ventricular Free Wall Rupture Complicating Acute Myocardial Infarction - Roque Pifarré, MD
    Ventricular Septal Rupture Secondary to Acute Myocardial Infarction - Alvaro Montoya, MD
    Repair of Left Ventricular Aneurysm - Roque Pifarré, MD
    Surgery for Ischemic Mitral Regurgitation - Brian K. Foy, MD
Komentarze (0)